Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

52.62M

Market cap52.62M

Price-Earnings ratio

-1.85

Price-Earnings ratio-1.85

Dividend yield

—

Dividend yield—

Average volume

275.61K

Average volume275.61K

High today

$3.69

High today$3.69

Low today

$3.45

Low today$3.45

Open price

$3.49

Open price$3.49

Volume

136.43K

Volume136.43K

52 Week high

$14.20

52 Week high$14.20

52 Week low

$2.64

52 Week low$2.64

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.